[Elsevier] Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial |
Reward10points
Best Answer |
| |
post
reply
points
385
10
Design and development of surface modified epigallocatechin 3-gallate NanoCubogel for localized delivery to oral submucous fibrosis therapy
10
Improving the performance of V2O5/rGO hybrid nanocomposites for photodetector applications
10
Fabrication, simulation, and characterization of planar inductors
10
Exposing digital image forgeries from statistical footprints
10
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
